Get Started

ARTL

NASD Artelo Biosciences Inc
Oct 29, 2026 · 8:05 AM ET LAST TRADE Market Closed

$2.44 ↑ +0.11 (+4.72%) Trading Up from the previous close of $2.33

YTD change
-92.59%
vs 20-day SMA
-16.72%
vs 200-day SMA
-88.99%

Price ranges

Previous day
$2.24 $2.42
open $2.24 close $2.33
+$0.09 (+4.02%)
Today
$0.00 $0.00
$2.44
Past week
$2.05 $2.66
from $2.56 now $2.44
-$0.12 (-4.69%)
Past month
$2.05 $4.07
from $4.04 now $2.44
-$1.60 (-39.60%)
This year
$0.52 $32.94
from $32.94 now $2.44
-$30.50 (-92.59%)

Price & Performance

-1.08 (-31.67%) / 6M

$0.1291$2.70$5.27$7.84Apr 29Jul 30Oct 28

Signals & Sentiment

Momentum, market sentiment, and recent alerts

Not So Good
  • The stock is 100.0% away from all-time highs of $12,150.00
  • ARTL is down 93% since the beginning of the year
  • ARTL is down 97% over the past 12 months
  • ARTL is down 40% over the past 1 month
  • 9% of all ARTL investors are betting against ARTL

ARTL reads not so good: price sits below both the 20- and 200-day averages, the 12-month move is -34.0%.

Financial Strength

Earnings, valuation, and balance sheet

Earnings

Profitable No
EPS $-8.01
Earnings momentum N/A Quarterly EPS growth
Quarterly change N/A

Valuation

P/E ratio N/A
Enterprise value $-3446890.0
Beta -1.09

Balance sheet & scale

IncomeN/A
RevenueN/A
Cash$4.2M
Debt$49.0
Income / Debt N/A

Company & Peers

Company profile and competitor comparison

Company profile

ExchangeNASD
Sector Professional, Scientific, and Technical Services
Industry Group Scientific Research and Development Services
Market cap $1.2M

Artelo Biosciences, Inc. is a clinical stage biopharmaceutical company, which focuses on the development of therapeutics that target lipid-signaling pathways, including the endocannabinoid system. Its product candidate pipeline includes ART27.13-Synthetic Cannabinoid Agonist, ART26.12-FABP5 inhibitor, and ART12.11-Synthetic CBD Cocrystal. The company was founded on May 2, 2011 and is headquartered in Solana Beach, CA.

Competitor comparison

TickerCompany PriceChange
AMGN Amgen Inc. $451.83 +0.87%
MRNA Moderna, Inc. $214.17 +2.98%
RVMD Revolution Medicines, Inc. $188.72 +1.34%
ROIV Roivant Sciences Ltd. $37.11 +1.56%
BNTX BioNTech SE Sponsored ADR $87.99 +1.07%

You looked up one stock
Trade Ideas watches them all

Real-time scanning and AI-generated signals across the entire market.

See plans TI Pro Download

Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.